1. Home
  2. UFI vs KPTI Comparison

UFI vs KPTI Comparison

Compare UFI & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unifi Inc. New

UFI

Unifi Inc. New

HOLD

Current Price

$3.57

Market Cap

74.1M

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$5.70

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFI
KPTI
Founded
1969
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
172.6M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
UFI
KPTI
Price
$3.57
$5.70
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$14.67
AVG Volume (30 Days)
21.8K
1.2M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
57.47
N/A
EPS
N/A
N/A
Revenue
$571,344,000.00
$146,067,000.00
Revenue This Year
$1.39
N/A
Revenue Next Year
$12.57
$46.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.57
52 Week Low
$2.96
$3.51
52 Week High
$5.68
$10.99

Technical Indicators

Market Signals
Indicator
UFI
KPTI
Relative Strength Index (RSI) 44.86 33.83
Support Level $3.50 $5.48
Resistance Level $3.80 $6.65
Average True Range (ATR) 0.14 0.75
MACD -0.00 -0.24
Stochastic Oscillator 41.67 15.84

Price Performance

Historical Comparison
UFI
KPTI

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: